Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
Targeted therapies require information on specific defective signaling pathways or mutations. Advances in genomic technologies and cell biology have led to identification of new therapeutic targets associated with signal-transduction pathways. Survival times of patients with colorectal cancer (CRC)...
Main Authors: | Heng, Fong Seow, Wai, Kien Yip, Fifis, Theodora |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | http://psasir.upm.edu.my/id/eprint/54981/1/Advances%20in%20targeted%20and%20immunobased%20therapies.pdf |
Similar Items
-
The current status of immunobased therapies for metastatic renal-cell carcinoma
by: Sathianathen NJ, et al.
Published: (2017-12-01) -
Identifying common mutations in colorectal cancer using a 7-gene panel by next generation sequencing
by: Chai, Boon Lee, et al.
Published: (2019) -
Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and â-catenin and enhances invasion in nasopharyngeal carcinoma cells.
by: Wai, Kien Yip, et al.
Published: (2012) -
Loss of interleukin17RA expression is associated with tumour progression in colorectal carcinoma
by: Chai, Boon Yean, et al.
Published: (2020) -
Differential effects of dishevelled 2 and 3 on TCF/ LEF- mediated transcriptional activation in wnt-3atreated breast cancer cell line MDA-MB-231
by: Khoo, Samuel Leon Juan, et al.
Published: (2017)